Guaifenesin 400 MG Oral Tablet — RxCUI 359601
RxNorm drug concept · Semantic clinical drug
RxCUI 359601
Semantic clinical drug · SCD
● Current RxNorm concept 58 FDA products
85 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI359601
Official nameGuaifenesin 400 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped58
Package NDCs mapped85
Reported Medicaid activity (SDUD)109,762 prescriptions · 25 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Guaifenesin: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Guaifenesin doesn't suppress your cough — it actually makes it work better. It loosens and thins the mucus in your chest so your cough can move it out of your airways more effectiv...
- What exactly does guaifenesin do — does it actually stop my cough?
- No — extended-release tablets like 12 Hour Mucus Relief and 365 Whole Foods Market Guaifenesin must be swallowed whole. Crushing, chewing, or breaking them releases the medicine al...
- Can I crush or split the extended-release tablet to make it easier to swallow?
🕸️ Concept Web — How Guaifenesin 400 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Guaifenesin 400 MG Oral Tablet
RxCUI 359601 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Guaifenesin
5032IN
-
Guaifenesin
-
Brand names 4
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Allfen Jr
705754BN -
Bidex
215678BN -
Liquibid
218036BN -
Refenesen
1086862BN
-
Allfen Jr
-
Dose forms 18
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Guaifenesin Oral Tablet
372360SCDF -
Guaifenesin Oral Product
1159704SCDG -
Guaifenesin Pill
1159705SCDG -
Guaifenesin Oral Tablet [Allfen Jr]
705756SBDF -
Guaifenesin Oral Tablet [Bidex]
541808SBDF -
Guaifenesin Oral Tablet [Liquibid]
701360SBDF -
Guaifenesin Oral Tablet [Refenesen]
1086864SBDF -
Allfen Jr Oral Product
1167856SBDG - +10 more in this family
-
Guaifenesin Oral Tablet
-
Clinical & branded drugs 9
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Guaifenesin 400 MG
316015SCDC -
Guaifenesin 400 MG Oral Tablet [Allfen Jr]
705757SBD -
Guaifenesin 400 MG Oral Tablet [Bidex]
541809SBD -
Guaifenesin 400 MG Oral Tablet [Liquibid]
701361SBD -
Guaifenesin 400 MG Oral Tablet [Refenesen]
1086867SBD -
Guaifenesin 400 MG [Allfen Jr]
705755SBDC -
Guaifenesin 400 MG [Bidex]
541807SBDC -
Guaifenesin 400 MG [Liquibid]
701359SBDC - +1 more in this family
-
Guaifenesin 400 MG
Showing up to 8 concepts per family — 21 of 32 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Guaifenesin 400 MG
SCDC · 316015 -
Guaifenesin Oral Tablet
SCDF · 372360 -
Guaifenesin Oral Product
SCDG · 1159704 -
Guaifenesin Pill
SCDG · 1159705
Brand-Name Concepts
-
Guaifenesin 400 MG Oral Tablet [Allfen Jr]
SBD · 705757 -
Guaifenesin 400 MG Oral Tablet [Bidex]
SBD · 541809 -
Guaifenesin 400 MG Oral Tablet [Liquibid]
SBD · 701361 -
Guaifenesin 400 MG Oral Tablet [Refenesen]
SBD · 1086867 -
Guaifenesin 400 MG [Allfen Jr]
SBDC · 705755 -
Guaifenesin 400 MG [Bidex]
SBDC · 541807 -
Guaifenesin 400 MG [Liquibid]
SBDC · 701359 -
Guaifenesin 400 MG [Refenesen]
SBDC · 1086866 -
Guaifenesin Oral Tablet [Allfen Jr]
SBDF · 705756 -
Guaifenesin Oral Tablet [Bidex]
SBDF · 541808
📦 FDA Products & Package NDCs
58 products · 85 package NDCs
85 package NDCs map to RxCUI 359601 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00363-0532-01 | 1 BOTTLE, PLASTIC in 1 CARTON (0363-0532-01) / 30 TABLET, F... | Mucus Relief | Walgreen Company | 2005-12-22 |
| 00363-0532-32 | 2 BOTTLE, PLASTIC in 1 CARTON (0363-0532-32) / 60 TABLET, F... | Mucus Relief | Walgreen Company | 2005-12-22 |
| 00536-1311-08 | 60 TABLET in 1 BOTTLE, PLASTIC (0536-1311-08) | Rugby Chest Congestion Relief G450 | Rugby Laboratories | 2020-09-01 |
| 10135-0790-30 | 30 TABLET in 1 BOTTLE (10135-790-30) | Guaifenesin 400mg | Marlex Pharmaceuticals Inc | 2024-03-01 |
| 10135-0790-60 | 60 TABLET in 1 BOTTLE (10135-790-60) | Guaifenesin 400mg | Marlex Pharmaceuticals Inc | 2024-03-01 |
| 10956-0059-30 | 1 BOTTLE, PLASTIC in 1 CARTON (10956-059-30) / 30 TABLET in... | DG Health Immediate Release Mucus Relief | Reese Pharmaceutical Co | 2013-12-01 |
| 10956-0845-30 | 1 BOTTLE, PLASTIC in 1 CARTON (10956-845-30) / 30 TABLET in... | Refenesen Mucus Relief | Reese Pharmaceutical Co | 2021-04-15 |
| 16103-0379-04 | 1 BOTTLE, PLASTIC in 1 CARTON (16103-379-04) / 30 TABLET in... | GUAIFENESIN | Pharbest Pharmaceuticals, Inc. | 2018-05-01 |
| 17714-0152-01 | 100 TABLET in 1 BOTTLE (17714-152-01) | Mucus Relief | Advance Pharmaceutical Inc. | 2016-11-01 |
| 24385-0602-65 | 30 TABLET in 1 BOTTLE, PLASTIC (24385-602-65) | Good Neighbor Pharmacy Mucus Relief | AmerisourceBergen Drug Corp | 2018-10-02 |
| 24385-0602-71 | 1 BOTTLE, PLASTIC in 1 CARTON (24385-602-71) / 50 TABLET in... | Good Neighbor Pharmacy Mucus Relief | AmerisourceBergen Drug Corp | 2018-10-02 |
| 24689-0144-01 | 100 TABLET in 1 BOTTLE (24689-144-01) | Guaifenesin | APNAR PHARMA LP | 2022-08-05 |
| 30142-0471-30 | 1 BOTTLE, PLASTIC in 1 CARTON (30142-471-30) / 30 TABLET in... | Kroger Mucus Relief | THE KROGER CO | 2021-03-03 |
| 36800-0794-50 | 1 BOTTLE, PLASTIC in 1 CARTON (36800-794-50) / 50 TABLET in... | TopCare Chest Congestion Relief | TOPCO ASSOCIATES LLC | 2013-12-01 |
| 37835-0401-40 | 40 TABLET in 1 BOTTLE (37835-401-40) | Mucus Relief | Bi-Mart | 2025-05-01 |
| 41163-0113-50 | 1 BOTTLE, PLASTIC in 1 CARTON (41163-113-50) / 50 TABLET in... | Equaline Chest Congestion Relief | United Natural Foods, Inc. dba UNFI | 2013-12-01 |
| 41226-0272-03 | 30 TABLET in 1 BOTTLE (41226-272-03) | MUCUS RELIEF | KROGER COMPANY | 2019-06-03 |
| 41250-0713-50 | 1 BOTTLE, PLASTIC in 1 CARTON (41250-713-50) / 50 TABLET in... | Meijer Chest Congestion Relief | Meijer Distribution Inc. | 2013-12-01 |
| 46122-0794-61 | 1 BOTTLE, PLASTIC in 1 CARTON (46122-794-61) / 50 TABLET, F... | Mucus Relief | Amerisource Bergen | 2024-08-08 |
| 49348-0729-09 | 2 BLISTER PACK in 1 CARTON (49348-729-09) / 12 TABLET in 1... | Chest Congestion Relief | Strategic Sourcing Services LLC | 2019-08-29 |
| 49483-0272-00 | 100000 TABLET in 1 CARTON (49483-272-00) | MUCOSA | TIME CAP LABORATORIES,INC | 2012-04-16 |
| 49483-0272-06 | 60 TABLET in 1 BOTTLE, PLASTIC (49483-272-06) | MUCOSA | TIME CAP LABORATORIES,INC | 2012-04-16 |
| 49483-0272-20 | 200 TABLET in 1 BOTTLE (49483-272-20) | MUCOSA | TIME CAP LABORATORIES,INC | 2023-09-15 |
| 50804-0371-30 | 1 BOTTLE in 1 CARTON (50804-371-30) / 30 TABLET in 1 BOTTLE | Mucus Relief Immediate Release | Good Sense | 2021-05-05 |
| 53499-5295-00 | 30 TABLET in 1 BOTTLE (53499-5295-0) | Respiratory Relief | Schwabe North America, Inc | 2025-07-29 |
| 54257-0776-21 | 60 TABLET in 1 BOTTLE (54257-776-21) | Mucosa Guifenesin | Magno-Humphries, Inc. | 2020-01-24 |
| 54738-0981-30 | 30 TABLET in 1 BOTTLE (54738-981-30) | Mucus Relief | Richmond Pharmaceuticals, Inc. | 2016-03-01 |
| 54738-0981-60 | 60 TABLET in 1 BOTTLE (54738-981-60) | Mucus Relief | Richmond Pharmaceuticals, Inc. | 2016-03-01 |
| 55319-0891-30 | 1 BOTTLE in 1 CARTON (55319-891-30) / 30 TABLET in 1 BOTTLE | Family Wellness Chest Congestion Relief | Family Dollar Services Inc | 2023-09-14 |
| 55681-0311-03 | 300 TABLET in 1 BOTTLE (55681-311-03) | Mucus Relief | TWIN MED LLC | 2022-07-01 |
| 57631-0012-00 | 28000 TABLET in 1 BOX (57631-012-00) | Guaifenesin 400 | InvaTech Pharma Solutions LLC | 2021-01-13 |
| 57896-0714-01 | 100 TABLET in 1 BOTTLE (57896-714-01) | MUCUS RELIEF | Geri-Care Pharmaceuticals, Corp | 2021-02-01 |
| 57896-0794-01 | 100 TABLET in 1 BOTTLE (57896-794-01) | MUCUS RELIEF | Geri-Care Pharmaceuticals, Corp | 2012-01-01 |
| 57896-0794-06 | 60 TABLET in 1 BOTTLE (57896-794-06) | MUCUS RELIEF | Geri-Care Pharmaceuticals, Corp | 2018-09-01 |
| 62011-0060-01 | 1 BOTTLE in 1 CARTON (62011-0060-1) / 50 TABLET in 1 BOTTLE | HealthMart Chest Congestion Relief | Strategic Sourcing Services LLC | 2019-08-29 |
| 63868-0998-50 | 1 BOTTLE in 1 CARTON (63868-998-50) / 50 TABLET in 1 BOTTLE | Quality Choice Mucus Relief | Chain Drug Marketing Association | 2012-08-01 |
| 63941-0987-50 | 1 BOTTLE, PLASTIC in 1 CARTON (63941-987-50) / 50 TABLET in... | Always Save Chest Congestion Relief GUAF | Valu Merch | 2023-02-06 |
| 66424-0001-01 | 100 TABLET in 1 BOTTLE (66424-001-01) | MUCUS RELIEF | SDA Laboratories, Inc. | 2025-07-01 |
| 68210-4158-01 | 1 BOTTLE in 1 BOTTLE (68210-4158-1) / 15 TABLET in 1 BOTTLE | MUCUS RELIEF | Prodose, Inc. | 2021-05-25 |
| 68998-0845-50 | 1 BOTTLE, PLASTIC in 1 CARTON (68998-845-50) / 50 TABLET in... | Marcs Mucus Relief | Marc Glassman Inc | 2020-02-26 |
| 69168-0370-01 | 100 TABLET in 1 BOTTLE (69168-370-01) | Mucus Relief Immediate Release | Allegiant Health | 2014-12-23 |
| 69168-0370-02 | 150 TABLET in 1 BOTTLE (69168-370-02) | Mucus Relief Immediate Release | Allegiant Health | 2023-11-06 |
| 69168-0370-17 | 300 TABLET in 1 BOTTLE (69168-370-17) | Mucus Relief Immediate Release | Allegiant Health | 2019-03-28 |
| 69168-0370-30 | 1 BOTTLE in 1 CARTON (69168-370-30) / 30 TABLET in 1 BOTTLE | Mucus Relief Immediate Release | Allegiant Health | 2014-12-23 |
| 69168-0370-41 | 1 BOTTLE in 1 CARTON (69168-370-41) / 15 TABLET in 1 BOTTLE | Mucus Relief Immediate Release | Allegiant Health | 2014-12-23 |
| 69168-0370-60 | 60 TABLET in 1 BOTTLE (69168-370-60) | Mucus Relief Immediate Release | Allegiant Health | 2022-06-08 |
| 69168-0916-60 | 1 BOTTLE in 1 CARTON (69168-916-60) / 60 TABLET in 1 BOTTLE | Mucus Relief Immediate Release | Allegiant Health | 2021-04-19 |
| 69517-0005-02 | 200 TABLET in 1 BOTTLE (69517-005-02) | Mucus Relief | HealthLife of USA LLC | 2025-09-26 |
| 69517-0005-03 | 300 TABLET in 1 BOTTLE (69517-005-03) | Mucus Relief | HealthLife of USA LLC | 2025-09-26 |
| 69517-0005-60 | 60 TABLET in 1 BOTTLE (69517-005-60) | Mucus Relief | HealthLife of USA LLC | 2025-09-26 |
Observed labelers:
Bryant Ranch Prepack (15) ·
Allegiant Health (7) ·
Pioneer Life Sciences, LLC (7) ·
Geri-Care Pharmaceuticals, Corp (3) ·
HealthLife of USA LLC (3) ·
Strategic Sourcing Services LLC (3)
· +38 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.